Kane Biotech Inc logo

Kane Biotech Inc

OTCPK:KNBIF (Canada)  
$ 0.09 -0.0162 (-15.28%) 10:08 PM EST
At Loss
Market Cap:
$ 13.37M
Enterprise V:
$ 19.53M
Volume:
-
Avg Vol (2M):
14.93K
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
14.93K

Business Description

Description
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset -1.86
Debt-to-Equity -0.88
Debt-to-EBITDA -2.92
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -12.75
Distress
Grey
Safe
Beneish M-Score -5.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.73
9-Day RSI 49.74
14-Day RSI 53.97
6-1 Month Momentum % 29.12
12-1 Month Momentum % -18.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.34
Quick Ratio 0.32
Cash Ratio 0.07
Days Inventory 6006.12
Days Sales Outstanding 536.48
Days Payable 4576.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.7
Shareholder Yield % -13.95
Name Current Vs Industry Vs History
Gross Margin % 73.83
Operating Margin % -2253.69
Net Margin % -3378.52
FCF Margin % -1758.25
ROA % -88.75
ROIC % -35.32
ROC (Joel Greenblatt) % -280.59

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 67.5
EV-to-EBIT -7.86
EV-to-EBITDA -8.29
EV-to-Revenue 176.52
EV-to-FCF -10.71
Earnings Yield (Greenblatt) % -12.72
FCF Yield % -13.79